Clinical Trial Update: Effect of GLP-1 and GIP on Insulin Secretion in Type-1 Diabetes Mellitus [NA]

View source ↗

Summary

This document provides an update on a completed clinical trial evaluating whether glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypepti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• GIP (glucose-dependent insulinotropic polypeptide)
• GLP-1 (glucagon-like peptide-1)

Snippet

Sponsor: Hvidovre University Hospital | Conditions: Type-1 Diabetes Mellitus | NA | Status: COMPLETED